Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-18.81%
↓ 189% below average
Average (9y)
21.05%
Historical baseline
Range
High:74.48%
Low:-19.60%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2025 | -18.81% |
| 2024 | -19.60% |
| 2023 | -0.61% |
| 2022 | -5.51% |
| 2021 | 27.32% |
| 2020 | -3.84% |
| 2019 | 49.93% |
| 2018 | 65.11% |
| 2017 | 41.99% |
| 2016 | 74.48% |